|
POGK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.03079999483435E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.19109999996425E-06 |
| Normal-vs-Stage2 |
5.978100E-04 |
| Normal-vs-Stage3 |
2.59139999458924E-08 |
| Normal-vs-Stage4 |
7.0025999998613E-07 |
| Stage1-vs-Stage2 |
9.876200E-01 |
| Stage1-vs-Stage3 |
2.534000E-02 |
| Stage1-vs-Stage4 |
1.541830E-01 |
| Stage2-vs-Stage3 |
1.444820E-01 |
| Stage2-vs-Stage4 |
3.109000E-01 |
| Stage3-vs-Stage4 |
6.360600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.5309999984735E-08 |
| Normal-vs-AfricanAmerican |
2.05919999999304E-05 |
| Normal-vs-Asian |
3.277600E-01 |
| Caucasian-vs-AfricanAmerican |
7.552200E-01 |
| Caucasian-vs-Asian |
3.164400E-01 |
| AfricanAmerican-vs-Asian |
2.626200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.49589995945831E-09 |
| Normal-vs-Female |
7.9001000000023E-05 |
| Male-vs-Female |
1.163740E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.115770E-01 |
| Normal-vs-Age(41-60Yrs) |
1.07620000022735E-07 |
| Normal-vs-Age(61-80Yrs) |
5.22030000338347E-08 |
| Normal-vs-Age(81-100Yrs) |
2.391800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.765600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.272600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.942600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.224000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.764600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.986000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.346800E-01 |
| Normal-vs-Grade 2 |
3.52319999996631E-06 |
| Normal-vs-Grade 3 |
5.03649999483713E-09 |
| Normal-vs-Grade 4 |
5.67290000530463E-08 |
| Grade 1-vs-Grade 2 |
3.127000E-01 |
| Grade 1-vs-Grade 3 |
8.548100E-02 |
| Grade 1-vs-Grade 4 |
4.645700E-02 |
| Grade 2-vs-Grade 3 |
3.196500E-02 |
| Grade 2-vs-Grade 4 |
9.595600E-03 |
| Grade 3-vs-Grade 4 |
3.032600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.177900E-04 |
| Normal-vs-ccB subtype |
7.70510000247526E-08 |
| ccA subtype-vs-ccB subtype |
7.240600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.96580004788672E-09 |
| Normal-vs-N1 |
6.939200E-01 |
| N0-vs-N1 |
2.656600E-01 |
|
|
